These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 18454461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L, Jacob S, Hubbard E.
    Cancer; 2008 Feb 25; 114(1):34-48. PubMed ID: 18186493
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems.
    Pirog EC, Erroll M, Harigopal M, Centeno BA.
    Arch Pathol Lab Med; 2004 May 25; 128(5):527-32. PubMed ID: 15086283
    [Abstract] [Full Text] [Related]

  • 5. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
    Olaharski AJ, Eastmond DA.
    Cancer; 2004 Jun 25; 102(3):192-9. PubMed ID: 15211479
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ, Qureshi MN.
    Diagn Cytopathol; 2005 Aug 25; 33(2):138-43. PubMed ID: 16007672
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
    Howell LP, Gurusinghe S, Tabnak F.
    Diagn Cytopathol; 2009 Feb 25; 37(2):103-10. PubMed ID: 19021201
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
    Kurman RJ, Malkasian GD, Sedlis A, Solomon D.
    Obstet Gynecol; 1991 May 25; 77(5):779-82. PubMed ID: 1849626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Doxtader EE, Brainard JA, Underwood D, Chute DJ.
    Cancer Cytopathol; 2017 Jan 25; 125(1):60-69. PubMed ID: 27731938
    [Abstract] [Full Text] [Related]

  • 18. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C, Austin RM.
    Cancer; 2008 Aug 25; 114(4):242-8. PubMed ID: 18484643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.